FRIDAY, May 2, 2025 (HealthDay News) -- For children using fluticasone propionate, the withdrawal of the brand-name drug (Flovent) was associated with increased discontinuation of inhaled steroid ...

In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children. The pharma company continued to sell a chemically identical ...

A Medicaid policy change left fewer kids with access to an asthma inhaler Children were more likely to have no asthma inhaler after GlaxoSmithKline withdrew Flovent from the market GSK withdrew ...

In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children. The pharma company continued to sell a chemically identical ...

A new study suggests the discontinuation of common asthma drug Flovent was linked to a higher rate of children halting inhaled steroid therapy altogether. In January 2024, a manufacturer stopped ...

The market withdrawal of the brand-name asthma drug fluticasone propionate (Flovent) was linked to increased discontinuation of inhaled steroid therapy among children who had used the drug ...

GSK stopped production of Flovent, a prescription drug for asthmatics age 4 or older, on January 1, 2024. The discontinuation aligned perfectly with the day in which the American Rescue Plan ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

Patients meeting all entry criteria discontinued their BDP or TA and were randomly assigned to receive one of the following inhaled treatments for 24 weeks: (i) FP (Flovent Rotadisk®,Glaxo ...

Flovent HFA, GSK’s brand name for its discontinued inhaler, hasn’t been available since December 2023 when, in response to new federal price limits, the company introduced an essentially ...

GSK halted manufacturing its Flovent HFA and Flovent Diskus fluticasone propionate inhalers in January. As a result of this, three types of asthma encounter rates went up. Following the ...

Data from over 3 million people who had been using Flovent showed a 17.5% increase in asthma-related hospitalization in the three months after Flovent was discontinued, and a 24.1% increase in the ...